Pharma BD Deal Intelligence

GlaxoSmithKline plc / Domantis Limited

2007 · Licensing/Option · $454M · Complete

Announcement Sentiment

100

Strongly positive

GlaxoSmithKline acquired Domantis Limited, a Cambridge UK domain-antibody (dAb) developer, for GBP 230M (~$454M) in cash to extend its biologics platform. Remove the trailing 'Source:' clause.

Key facts

Announced Dec 21, 2007
Deal value $454M
Deal type Licensing/Option

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals